William Raymond Lumry MD
Asthma & Allergic Conditions, Pediatric Asthma & Allergic Conditions
Allergy & Allergy Specialists
Join to View Full Profile
5323 Harry Hines BoulevardDallas, TX 75390
Phone+1 214-373-7374
Fax+1 214-373-7003
Dr. Lumry is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Scripps Clinic/Scripps Green HospitalFellowship, Allergy and Immunology, 1982
- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1977 - 1980
- Washington University/B-JH/SLCH ConsortiumInternship, Internal Medicine, 1977 - 1978
- University of Texas Medical Branch School of MedicineClass of 1977
Certifications & Licensure
- TX State Medical License 1977 - 2025
- CA State Medical License 1980 - 1984
- American Board of Allergy and Immunology Allergy & Immunology
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Super Doctor SuperDoctors.com
- Top MD Consumers Checkbook
- Join now to see all
Clinical Trials
- A Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE Start of enrollment: 2009 Aug 31
- Observational Safety Study for KALBITOR (Ecallantide) in the Treatment of Acute Attacks of Hereditary Angioedema Start of enrollment: 2010 Feb 01
- A Pharmacokinetic, Tolerability and Safety Study of Icatibant in Children and Adolescents With Hereditary Angioedema Start of enrollment: 2012 Jan 27
- Join now to see all
Publications & Presentations
PubMed
- Safety and pharmacokinetics of long-acting plasma kallikrein inhibitor navenibart (STAR-0215) in healthy adults.William Lumry, Michele Gunsior, Theodora Cohen, Kristine Bernard, Pamela Gustafson
Annals of Allergy, Asthma & Immunology. 2025-03-28 - Hereditary Angioedema With Normal C1 Inhibitor: A Quarter Century of Forward Progress and Persisting Obstacles.Sandra C Christiansen, Aleena Banerji, Jonathan A Bernstein, Paula J Busse, Timothy Craig
The Journal of Allergy and Clinical Immunology. in Practice. 2025-03-07 - Interplay between on-demand treatment trials for hereditary angioedema and treatment guidelines.Danny M Cohn, Daniel F Soteres, Timothy J Craig, William R Lumry, Markus Magerl
The Journal of Allergy and Clinical Immunology. 2025-03-01
Journal Articles
- Effect of Lanadelumab Compared with Placebo on Prevention of Hereditary Angioedema AttacksJonathan A Bernstein, Lawrence B Schwartz, Andrew M Smith, H James Wedner, Daniel Soteres, Timothy Craig, Douglas T Johnston, Aleena Banerji, Paula J Busse, William R ..., JAMA
- Population Pharmacokinetics of Subcutaneous C1‐Inhibitor for Prevention of Attacks in Patients with Hereditary AngioedemaJonathan A Bernstein, Marc A Riedl, Bruce Zuraw, H Henry Li, Timothy Craig, William R Lumry, Clinical and experimental allergy
Press Mentions
- HAE Patients Want New Preventive Treatments, Survey SaysMay 1st, 2025
- New Harris Poll Findings Reveal HAE Patients Are Unsatisfied with Current Prophylactic Treatment Options, with over 90% Interested in Trying New TherapiesApril 29th, 2025
- KalVista Pharmaceuticals Presents New Sebetralstat Data at the 2024 American College of Allergy Asthma and ImmunologyOctober 28th, 2024
- Join now to see all
Professional Memberships
- Fellow
- American College of Allergy, Asthma and ImmunologyFellow
- Member
- Dallas County Medical SocietyMember
Other Languages
- Spanish
External Links
- Allergy & Asthma Specialistshttp://www.allergyspecialists.us
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
